Key Metrics of Novavax
Revenue$984M▼ 50.4% YoYFY 2023
Operating income−$567M▲ 12.1% YoY
Net profit−$545M▲ 17.2% YoY
Shareholders' equity−$717M
Market cap$1.7BNVAX · $10.08
Competitors10identified
About Novavax
Sectors
Company details
- Website
- es.novavax.com
- Listed
- Nasdaq: NVAX
Operational Areas of Novavax
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameNovavax Inc.
TickerNVAX
ExchangeNasdaq
CountryUnited States
SEC CIK0001000694
Listed since—
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://es.novavax.com
US market & SEC filings
NVAX · Nasdaq · SEC CIK 0001000694
Last price · 02 Nov 2026
$10.08
−3.73%
Market cap$1.7B
P/E—On FY 2023 diluted EPS
Volume4,061,779
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited States
NVAX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeGaithersburg
GSTIN—
Email—
Websitehttps://es.novavax.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Novavax
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.